When DLBCL cells with knocked-down CREBBP expression were treated with a selective HDAC3 inhibitor, H3K27 acetylation at the enhancers of multiple MHC II genes was rescued. The gene discussed is CREBBP; the disease is diffuse large B-cell lymphoma.